Pronounce: den-OH-sue-mab
Classification: Monoclonal Antibody
Denosumab is a type of monoclonal antibody. Monoclonal antibodies target a specific protein or cell – in this case, the target is a protein called RANKL, which helps the formation, function, and survival of osteoclasts that help with bone resorption. By targeting RANKL, bone resorption is decreased and bone mass and strength are increased.
Denosumab (Prolia®) is used to treat osteoporosis in men and postmenopausal women, including glucocorticoid-induced osteoporosis. It is also used in men receiving androgen deprivation therapy (ADT) for prostate cancer and in women taking aromatase inhibitor therapy. This medication is different from Denosumab (Xgeva®), which treats bone metastasis. They are used to treat different issues, are not interchangeable, and also should not be taken at the same time.
Denosumab (Prolia®) is usually given every 6 months by subcutaneous injection (SQ, given under the skin) in the upper arm, upper thigh, or abdomen (belly). You may need to take calcium and vitamin D supplements to help with your bone health and prevent your blood calcium levels from getting too low. If you miss a dose, take your missed dose as soon as possible.
There are a few things you can do to manage the side effects of denosumab (Prolia®). Talk to your care team about these recommendations. They can help you decide what will work best for you. These are some of the most common or important side effects:
This medication can cause your blood calcium levels to drop below normal. Calcium and vitamin D supplements can be taken to prevent the level from getting too low. Signs that calcium levels are low include numbness or tingling around the lips, muscle stiffness, twitching, spasms, or cramps. Be sure to call your care team if you have any of these symptoms. Tell your provider if you have chronic kidney disease before starting treatment with denosumab.
Patients taking this medication may have pain in their back and other parts of their body. Talk to your provider about how you can manage this pain.
Exposure of an unborn child to this medication could cause birth defects, so you should not become pregnant or father a child while on this medication. Effective birth control is necessary during treatment and for 5 months after treatment. Even if your menstrual cycle stops or you believe you are not producing sperm, you could still be fertile and conceive. You should consult with your healthcare team before breastfeeding while receiving this medication.
OncoLink is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through OncoLink should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem or have questions or concerns about the medication that you have been prescribed, you should consult your health care provider.
Information Provided By: www.oncolink.org | © 2025 Trustees of The University of Pennsylvania